Published in

American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 8(64), 2020

DOI: 10.1128/aac.00900-20

Links

Tools

Export citation

Search in Google Scholar

Suramin inhibits SARS-CoV-2 infection in cell culture by interfering with early steps of the replication cycle

Journal article published in 2020 by Clarisse Salgado-Benvindo ORCID, Clarisse Salgado Benvindo da Silva, Martijn J. van Hemert ORCID, Melissa Thaler ORCID, Ali Tas, Natacha S. Ogando ORCID, Peter J. Bredenbeek, Dennis K. Ninaber, Ying Wang, Pieter S. Hiemstra, Eric J. Snijder ORCID, M. J. Van Hemert
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic that originated in Wuhan, China, in December 2019 has impacted public health, society, the global economy, and the daily lives of billions of people in an unprecedented manner. There are currently no specific registered antiviral drugs to treat or prevent SARS-CoV-2 infections. Therefore, drug repurposing would be the fastest route to provide at least a temporary solution while better, more specific drugs are being developed.